![2020 Specialty Report: The Tisch Cancer Institute](http://res.cloudinary.com/broadcastmed/image/fetch/q_auto,c_fit,w_800,h_600,f_auto/http%3A%2F%2F55933-bcmed.s3.amazonaws.com%2Fbcp%2Fimages%2Fvmm%2FimgSource%2Fscreen-shot-2020-06-23-at-5.11.20-pm1.png)
2020 Specialty Report: The Tisch Cancer Institute
The Tisch Cancer Institute, a National Cancer Institute-designated cancer center, employs a multidisciplinary approach to cancer research and treatment, with the goal of advancing clinical breakthroughs that help prevent and eradicate cancer. Read the 2020 Specialty Report online for articles on:
- Novel In Situ Cancer Vaccine Shows Promising Results in Patients With Indolent B Cell Lymphoma
- Myeloma Drug Helps Patients With Few Treatment Options
- Optimal Dosing for Head and Neck Squamous Cell Cancer
- Therapies That Control Myeloproliferative Neoplasms
- Innovative Barcoding Technology Allows Scientists to Characterize the Biologic Effects of Genes
- Single-Cell Technology Provides a Close-Up View of How Immune Therapies Change the Microenvironment of Tumors
- Making Headway Against the Elusive RAS Oncogene
- Unmasking the Oncogene That Could Lead to New Therapies for Liver Cancer